Literature DB >> 28338187

The predictive value of baseline LDL-TG level on major adverse cardiovascular events in a followed up cohort population.

X-H Ding1, P Ye, X-N Wang, R-H Cao, X Yang, W-K Xiao, Y Zhang, Y-Y Bai, H-M Wu.   

Abstract

OBJECTIVE: We aimed at identifying the predictive roles of Low-Density Lipoprotein Triglycerides (LDL-TG) for major adverse cardiovascular events (MACEs). PATIENTS AND METHODS: A longitudinal study in a routine health check-up population was performed with an average follow-up of 4.8 years. The participants involved in this study were 1680, from 2007 to 2009, and all had followed-up for all-cause mortality, cardiovascular disease mortality, and the development of MACEs. The demographic information and anthropometric parameters at baseline were recorded. The baseline and follow-up conventional lipid parameters were measured. We also examined the level LDL-TG, as well as the relationship between its level and MACEs.
RESULTS: MACEs individuals were characterized by statistically higher baseline LDL-TG (17.22 ± 8.05 vs. 16.39 ±7.35 nmol/l, p = 0.017). The univariate regression for MACEs group indicated that the LDL-TG (b = 0.813, HR = 2.254, 95% CI: 1.454-3.494, p < 0.001), older age, sex and other factors were a significant risk for MACEs. Furthermore, in the adjusted Cox model showed that only higher baseline LDL-TG (b =0.512, HR = 1.669, 95% CI: 1.013-2.748, p = 0.044) and older age (b = 0.062, HR = 1.064, 95% CI: 1.034-1.094, p < 0.001, Table IV) were still predictors for MACEs.
CONCLUSIONS: Higher baseline LDL-TG closely associated with MACEs and it is a moderate and independent predictive factor for MACEs.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28338187

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  4 in total

1.  Metabolic Properties of Lowdensity Lipoprotein (LDL) Triglycerides in Patients with Type 2 Diabetes, Comparison with Small Dense LDL-Cholesterol.

Authors:  Tsutomu Hirano; Rieko Kodera; Takeshi Hirashima; Natsuko Suzuki; Ema Aoki; Mitsuru Hosoya; Taito Oshima; Toshiyuki Hayashi; Shinji Koba; Motoko Ohta; Noriyuki Satoh; Yasuki Ito
Journal:  J Atheroscler Thromb       Date:  2021-04-29       Impact factor: 4.394

2.  Serum metabolic biomarkers for synucleinopathy conversion in isolated REM sleep behavior disorder.

Authors:  Ariadna Laguna; Helena Xicoy; Eduardo Tolosa; Mònica Serradell; Dolores Vilas; Carles Gaig; Manel Fernández; Oscar Yanes; Joan Santamaria; Núria Amigó; Alex Iranzo; Miquel Vila
Journal:  NPJ Parkinsons Dis       Date:  2021-05-13

3.  Dyslipidemia in diabetic kidney disease classified by proteinuria and renal dysfunction: A cross-sectional study from a regional diabetes cohort.

Authors:  Tsutomu Hirano; Noriyuki Satoh; Rieko Kodera; Takeshi Hirashima; Natsuko Suzuki; Ema Aoki; Taito Oshima; Mitsuru Hosoya; Masahiro Fujita; Toshiyuki Hayashi; Yasuki Ito
Journal:  J Diabetes Investig       Date:  2021-11-02       Impact factor: 3.681

4.  Long-term prognostic utility of low-density lipoprotein (LDL) triglyceride in real-world patients with coronary artery disease and diabetes or prediabetes.

Authors:  Jing-Lu Jin; Hui-Wen Zhang; Ye-Xuan Cao; Hui-Hui Liu; Qi Hua; Yan-Fang Li; Yan Zhang; Yuan-Lin Guo; Na-Qiong Wu; Cheng-Gang Zhu; Rui-Xia Xu; Ying Gao; Xiao-Lin Li; Chuan-Jue Cui; Geng Liu; Jing Sun; Qian Dong; Raul Santos; Jian-Jun Li
Journal:  Cardiovasc Diabetol       Date:  2020-09-27       Impact factor: 9.951

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.